“[The] report suggests that the delay denies patients access to the most up-to-date treatments and cures without a corresponding increase in safety,” said Stephen J. Ubl, AdvaMed President and CEO, in a news release from AdvaMed.
When AdvaMed examined the rate of medical device safety recalls for the United States and Europe from 2005-2009, it was almost identical.
Read the AdvaMed news release about the study of medical device approval safety.
Read the report by clicking here (pdf).
Read more about medical devices:
– Medicare Patients Report Problems With Competitive Bidding Program
– Medical Device Market to Present Greater Opportunity, Greater Challenges to Companies
– New Device Manufacturer Tax Could Increase Medical Device Outsourcing
